Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 27, 2022

SELL
$72.5 - $100.68 $183,497 - $254,821
-2,531 Closed
0 $0
Q2 2021

Jul 22, 2021

SELL
$93.66 - $139.27 $2,247 - $3,342
-24 Reduced 0.94%
2,531 $315,000
Q4 2020

Jan 19, 2021

SELL
$99.61 - $142.12 $91,242 - $130,181
-916 Reduced 26.39%
2,555 $338,000
Q3 2020

Oct 09, 2020

BUY
$72.92 - $102.01 $253,105 - $354,076
3,471 New
3,471 $353,000
Q1 2020

Apr 16, 2020

SELL
$37.9 - $104.44 $143,262 - $394,783
-3,780 Closed
0 $0
Q4 2019

Jan 09, 2020

SELL
$77.66 - $99.74 $231,271 - $297,025
-2,978 Reduced 44.07%
3,780 $349,000
Q3 2019

Nov 08, 2019

BUY
$90.37 - $122.49 $275,447 - $373,349
3,048 Added 82.16%
6,758 $611,000
Q2 2019

Jul 19, 2019

BUY
$89.51 - $118.04 $2,685 - $3,541
30 Added 0.82%
3,710 $4.38 Million
Q1 2019

May 15, 2019

BUY
$61.98 - $96.5 $228,086 - $355,120
3,680 New
3,680 $3.19 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $9.36B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Meridian Wealth Management, LLC Portfolio

Follow Meridian Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meridian Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Meridian Wealth Management, LLC with notifications on news.